Morningstar Acciones

23andMe Holding Co ME

Último Precio
0,39
Cambio del día
-0,01|-2,86%

a 16/04/2024
17:02:55 EDT | USD  Minimum 15 Minutes Delay.

Bid/OffersRango del DíaVolumen90d Ave VolCapitalización
0,39 - 0,390,38 - 0,423.755.5346.581.545193,90Mill
Último Cierre52 Week RangeP/BeneficioDividendo %ISIN
0,400,38 - 2,26--US90138Q1085

Cotización 23andMe Holding Co

Mr. Lee Davidson, Head of Quantitative Research
The conduct of Morningstar's analysts is governed by Morningstar's Code of Ethics, Securities Trading and Disclosure Policy, and Investment Research Integrity Policy. For information regarding conflicts of interest, please click here.
Fair Value is derived from a detailed projection of a company’s future cash flows. Analysts create custom industry and company assumptions to feed income statement, balance sheet, and capital investment assumptions into a proprietary discounted cash flow modeling template. Scenario analysis, in-depth competitive advantage analysis, and a variety of other analytical tools are used to augment the discounted cash flow process. Combining analysts’ financial forecasts with the firm’s economic moat helps us assess how long returns on invested capital are likely to exceed the firm’s cost of capital. Because we are modeling free cash flow to the firm—representing cash available to provide a return to all capital providers—we discount future cash flows using the weighted average of the costs of equity, debt, and preferred stock (and any other funding sources), using expected future proportionate long-term, market-value weights. If our base-case assumptions are true the market price will converge on our fair value estimate over time, generally within three years. Investments in securities are subject to market and other risks. Past performance of a security may or may not be sustained in future and is no indication of future performance. For detail information about the Qualitative Fair Value, please click here.
Cuentas Financieras
202120222023
More...
Cuenta de Resultados
Ingresos243,92271,89299,49
Operating Income-185,20-254,15-324,01
Resultado Neto-183,62-217,49-311,66
Beneficio Básico por Acción-0,45-0,60-0,69
Num Medio Acciones diluidas en circulación406362452
Balance
Activo Corriente313,58601,79424,99
Activos no corrientes138,52550,28517,61
Total Activo 452,101.152,07942,60
Pasivo corriente121,62153,24149,42
Total Pasivo---
Total Equity-595,62915,66713,94
Flujo de Caja
Flujo de caja operativo-74,25-166,83-165,39
Inversiones de Capital-7,37-13,97-11,31
Flujo de Caja Libre-81,63-180,80-176,70

En millones, excepto "EPS básico". Currency is USD.

Perfil de la compañía

23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment include Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.

Sector

Atención sanitaria

Industria

Diagnósticos y Análisis

Estilo de acciones

Peq-Valor

Fin Ejercicio Fiscal

marzo

Empleados

816
Datos destacados
More...
Precio/Beneficio 12 m-0,36
Precio/Valor contable0,51
Price/Sales TTM0,76
Crec Ingresos (media 3 a)-0,66
Crec BPA (media 3 a)-
Margen operativo-108,19
Margen neto-104,06
ROE 12 m-38,25
Deuda/Fondos propios0,11
Dividendos
AntLatest
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0,000,00
Mr. Lee Davidson, Head of Quantitative Research
The conduct of Morningstar's analysts is governed by Morningstar's Code of Ethics, Securities Trading and Disclosure Policy, and Investment Research Integrity Policy. For information regarding conflicts of interest, please click here.
Fair Value is derived from a detailed projection of a company’s future cash flows. Analysts create custom industry and company assumptions to feed income statement, balance sheet, and capital investment assumptions into a proprietary discounted cash flow modeling template. Scenario analysis, in-depth competitive advantage analysis, and a variety of other analytical tools are used to augment the discounted cash flow process. Combining analysts’ financial forecasts with the firm’s economic moat helps us assess how long returns on invested capital are likely to exceed the firm’s cost of capital. Because we are modeling free cash flow to the firm—representing cash available to provide a return to all capital providers—we discount future cash flows using the weighted average of the costs of equity, debt, and preferred stock (and any other funding sources), using expected future proportionate long-term, market-value weights. If our base-case assumptions are true the market price will converge on our fair value estimate over time, generally within three years. Investments in securities are subject to market and other risks. Past performance of a security may or may not be sustained in future and is no indication of future performance. For detail information about the Qualitative Fair Value, please click here.
© Copyright 2024 Morningstar, Inc. Reservados todos los derechos.

Términos de uso        Política Privacidad        Cookie Settings        Aviso Legal